ArticleDentistry journal2018

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. A Commentary of the Pivotal Trial by Raje et al. Published on Lancet Oncology.

Vittorio Fusco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.